Skip to main content

Find Clinical Trials

Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,815 public trials 832 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital

NCT04345536

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: Oslo University Hospital Oslo, Norway

View Trial Details

Completed

To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection

NCT05474755

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: The First People's Hospital of Wenling Wenling, Zhejiang, China

View Trial Details

Completed

Burden of COVID-19 Infection in Populations With High or Low Risk of Infection

NCT04636203

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations: IRCCS INM Neuromed, Department of Epidemiology and Prevention Pozzilli, IS, Italy

ASST Settelaghi Varese, VA, Italy

View Trial Details

Completed

Assocation Between In-person Instruction and COVID-19 Risk

NCT04529421

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations: Oslo Metropolitan University Oslo, Norway

View Trial Details

Completed

Glasses Against Transmission of SARS-CoV-2 (COVID-19) in the Community

NCT05217797

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: Norwegian Institute of Public Health Oslo, Norway

View Trial Details

Completed

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

NCT05047770

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +15 more
Locations: GSK Investigational Site Tempe, Arizona, United States

GSK Investigational Site Oxnard, California, United States

GSK Investigational Site San Diego, California, United States

GSK Investigational Site San Diego, California, United States

View all 46 locations

View Trial Details

Completed

Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population

NCT00894257

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +19 more
Locations: CHU Montpellier Montpellier, France

CHU Nice Nice, France

CHU Toulouse Toulouse, France

View Trial Details

Completed

Understanding COVID-19 Infections in Pregnant Women and Their Babies in 5 African Nations (periCOVID Africa)

NCT05409274

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations: Aga Khan University Nairobi, Kenya

University of Malawi Zomba, Malawi

Fundação Manhiça Manhiça, Mozambique

MRC Unit The Gambia at LSHTM Fajara, The Gambia

View Trial Details

Completed

Tambua Mapema Plus - to Discover HIV Infection Early and Prevent Onward Transmission

NCT03508908

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: KEMRI Mtwapa Kilifi, Kenya

View Trial Details

Completed

Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%

NCT05264558

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Cairns and Hinterland Hospital and Health Service Cairns, Queensland, Australia

View Trial Details